Background: Epidemiology of extended-Spectrum-β-lactamases has become worldwide, and our aim was to establish the prevalence of isolates producer in university hospital center Yalgado OUEDRAOGO particularly in reanimation and emergencies units.
INTRODUCTION
Infectious diseases are a major cause of loss of productive years of life in the world, and more than 45% of deaths in low-income countries [1] . Bacterial infections are responsible for 70 % of cases of mortality caused by microorganisms. [2] These data are certainly linked to the occurrence of bacterial resistance and could be unfortunately constantly increased with the emergence of new resistances. Control of bacterial resistance is justified nobly motivated and constitute a public health priority for WHO. The mechanisms of resistance are widely documented. The enzymatically resistance consist in the production of enzymic proteins forwhoseβ-lactamases constitute a large family that inactive β-lactams antibiotics. The involved form of thoseenzymes called extended spectrum β-lactamases (ESBL) allow bacteria to resist to third or fourth generation cephalosporins [3] . ESBLs, worldwide documented are carried by several species of Gram negative bacilli for which a large proportion adapted to humans are responsible to clinical therapeutic failure. Molecular characterization of bacterial strains allows us to know the types of β-lactmases encoded. It is established that among main ESBL, blaCTX-M is more described than bla TEM and bla SHV. Faced with the global expansion of extended spectrum β-lactamase, clinical laboratories are most than ever called to screen isolates producing. Molecular methods conduce to determinebla-type but don't access to kinetic parameters which indicate the affinity between these enzymes and β-lactam antibiotics.Through this study we aimed to contribute to clear bacterial resistance byestablishing extended-spectrum β-lactamase profile of Gram negative bacilli that resist oxyiminocephalosporins at University Hospital Center Yalgado, Ouedraogousing microbiological and kinetic methods.
I.MATERIALS AND METHODS

I.1.Clinical specimens and bacterial strains
Bacterial strains collected during a prospective study from July 2009 to March 2012 were Gram negative bacilli that resist third generation of cephalosporin. They were isolated during diagnosis analysis of biological specimens. Different clinical specimens such as blood, urine, pus, vaginal swam, ascitic fluid, peritoneal fluid, and stool and rachis fluid samples were collected from hospitalized patients of emergencies and reanimation units. Samples were taken from infected patients who presented infectious evident symptoms like fever and purulent urine. Isolates were identified using conventional method [4] [6] were collected, purified and conserved at -80°C for furthers analysis. In order to screen ESBL phenotypical profile, isolates were submitted for synergy test [7] between third generation of cephalosporins disks (cefotaxime or ceftazidime) and amoxicillin plus clavulanic acid. In addition, MICs of ceftriaxone, antibiotic frequently used in clinical routine in our sanitary centers was performed as recommended by guide E-test AB BIODISK. I.3. Extraction and kinetics activity of β-lactamase From bacterial aliquot conserved 2µl of an inoculum were collected and suspended in 4ml of Luria Bertini solution. This bacterial suspension stirring, was cultured 24 hours overnight at 37°C. Bacterial culture resulting was centrifuged at 3000 rpmduring 30 minutes. The bacterial pellet which resulted was suspended in 500 µl of 100 mMphosphate buffer Ph7, and submited to physical method of freeze / thaw cycles [8, 9] .This treatment allowed to obtainperiplasmic contents and enzyme solution was obtained after a final centrifugation at 8000 rpm for 20 minutes. For certain bacterial strains, the enzyme production was induced with a solution of cefoxitin 20µg /ml during culture. Different bacterial extracts obtained were tested for β-lactamase activity with nitrocefin. A reaction medium consisting of 50 mM phosphate buffer pH7, enzyme (5 to 10µl) and nitrocefinat final concentration of 100 µM/ml was carried out in a spectrophotometer's tank. The extracts with a β-lactamase activity were tested with third-generation β-lactams in order to determine their hydrolytic profile (ESBL profile). For this purpose, solutions of antibiotics were used as substrate in a reaction medium where the final concentration of antibiotic varied increasingly (25 .mu.m, 50 .mu.m, 100 .mu.m and 75µM). The enzymatic activities were monitored at UV / VIS double beam Uvikon 923, XL appropriate wavelengths: 482 nm (nitrocefin) to 235nm (ampicillin, benzylpenicillin), at 260 nm (cefotaxime, ceftazidime, ceftriaxone, cefuroxime, cefepime). All these experiments were performed at 30 °C in 50mM phosphate buffer pH7. The initial velocity (V0) of hydrolysis of each compound (expressed as absorbance units per minute) was evaluated according to the relationship V0 = ∆A λ /∆t wherein ∆A λ /∆t represents the slope at the origin of the curve of variation Absorbance at the wave length λ λ λ λ relating to time. I.4. Determining the magnitude of kinetic parameters related to bacterial extracts Kinetic parameters Km and Vm witch represent respectively Michaelis constant linked to substrates and maximal velocity of enzymatic reaction were determined byHanse linearization based onMichaelis equation.
II. RESULTS
II.1. Antibiotic susceptibility testing and ESBL detection
After the isolation procedures, identification and antibacterial susceptibility testing, 259 bacilli Gramnegative resistant to at least one of third generation cephalosporin were collected. The bacterial strains identified using biochemical characteristics grouped in galleries (API 20E, minimum galleries) were distributed in the bacterial species as follows: Escherichia coli (n = 132), Klebsiellapneumoniae (n = 43), Pseudomonas aeruginosa (n = 34), Enterobactersp(n = 25), Citrobacterspp (n = 11) Acinetobacterbaumannii (n = 7), Proteus mirabilis (n = 6) and Salmonella typhi (n =1). On a Petri dish, these strains were found to be resistant to antibiotics targeted as cefotaxime, ceftriaxone, ceftazidime, cefepime, aztreonam and to a lesser extent to imipenem (Table IV) . For these antibiotics to which we particularly interested, the diameter of the inhibition of bacterial growth zones varied between 0 and 22 mm. The tests synergy revealed among the 259 strains, 188 (72.58%) ESBLproducing objectified by a synergy picture ( Figure  1 ). Antibiotic discsused in carrying out tests were Amoxicillin + clavulanic acid (20/10 ug) Ceftazidime (30µg) and Cefotaxime (30µg) cefepime (30µg), aztreonam (30µg). The distance between the antibiotic disks for the materialization of the synergistic picture in ESBL-producing strains varied from 10 to 15 mm.The study of theMICofceftriaxone ABBIODISKE-test,showed that the MIC was greater than 50 µg/ ml, 100 µg/ ml and 256µg/ml for 81.57%, respectively, 55.26% and 39.74% of isolates. 
III. 1. Antibiotic susceptibility testing and ESBL detection
Microbiological detection of ESBL production based on the synergy test is today a routine practice of laboratory diagnostics in low-income countries. Performed with the utmost care, it allows us to incriminate bacterial strains for which special attention should be given when prescribing antibiotics. ESBL phenotype of these strains is very often confirmed byan increase in MICs of antibiotics. Of 259 resistant strains we collected, 188 (56.7%) showed an ESBL phenotype on plates. The MIC values of ceftriaxone and cefotaxim we have determined for these strains were of the same order of magnitude as those determined by other authors for ESBL-producing strains [10, 11] .However, factors such as the distance between the discs of antibiotics for the materialization of the synergy image, the additional production of other β-lactmases (AmpC, MBL) can influence the result of thesynergy test [12] . The study of the kinetic activity of the bacterial extracts has allowed incriminating 171 ESBL-producing strains among the 259. It was revealed that the extracts of 17 yet positive bacterial strains in synergy test hydrolyzed no third generation cephalosporins. The breakfast strains were therefore not producing ESBL [13] . Detecting the ESBL by the enzymatic method could be considered a correction method for the synergistic test. In addition, this same method, if it does not determine the type of beta-lactamase in the presence of genes as molecular methods, allows through the values of the kinetic parameters to specify the nature of the affinity of the enzyme for antibiotics.
III.2. Frequency and biological distribution of ESBL producing strains
ESBL producing strains collected in our study are spread into bacterial species frequently reported by several authors. [18, 19, 20, and 21] .Note that Escherichiacoliis the most representative of commensal enterobacteria. Feces contain 13 x. 10 6 per gram in healthy subjects and this figure re ached in sick subjects to 10 11 [22] . The anatomical proximity of urinary and genital openings with the anal opening could facilitate the ano-genital spread of this bacterium, which by ascending way affects various organs of the urogenital system. This observation is more pointed in the emergency and reanimation units, where the condition of patients is associated with a lower level of hygiene.
III.3.Ecological niche of ESBL-producing strains detected
From results of our study, medical emergencies unit followed by those of Visceral Reanimation and Pediatric Emergencies appear to be most sources of ESBL producing strains. However it should be noted that in context of our country, the position of the medical emergencies unit can be relative, given its place in the organizational system of hospitals. Réa. poly.
Réa/ Maternité
Conclusion Detection of ESBL-producing bacterial strains is an important global concern. If nowadays molecular detection methods are the most recommended, it is indisputable that they remain inaccessible to lowincome countries. Phenotypical procedures are common practices in diagnostic laboratories. The enzyme method of detection of the production of β-lactamases that we have proposed is similar to cefinase tests performed in the clinical laboratory. The improvement of our process is that it provides opportunities to obtain kinetic parameters of enzymes that assess their affinity with antibiotics substrates. Through both microbiological and kinetic methods, we were able to establish data on bacterial species frequently responsible for antibiotic resistance in emergency units at the University Hospital Center, Yalgado, OUEDRAOGO. The affinity of the bacterial extracts for cefotaxim suggests that the major part of the strains harbors CTX-M type ESBLs. Urine samples from units of medical emergencies and visceral surgery reanimation appeared respectively as sources and ecological purveyors of ESBLproducing strains. The challenge lies in the development of reliable mechanisms to control the spread of these strains that contribute to high morbidity and mortality in our hospitals. These mechanisms should take into account a good hospital hygiene policy and also antibiotics management.
